Uric acid: A marker of increased cardiovascular risk

Ana C M Gagliardi1, Marcio H Miname, Raul D Santos

  • 1Lipid Clinic Heart Institute (InCor), University of Sao Paulo Medical School Hospital, Sao Paulo, Brazil.

Atherosclerosis
|July 1, 2008
PubMed

Insights

High uric acid levels are linked to cardiovascular disease and atherosclerosis risk factors. Further research is needed to confirm if lowering uric acid prevents cardiovascular events.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Nephrology

Background:

  • The link between uric acid and cardiovascular disease (CVD) has been recognized since the 19th century.
  • Elevated uric acid is associated with hypertension, obesity, insulin resistance, metabolic syndrome, and renal failure.
  • Specific genetic defects in purine metabolism are an exception to general hyperuricemia associations.

Purpose of the Study:

  • To review the established relationship between uric acid and cardiovascular disease.
  • To highlight the association of hyperuricemia with atherosclerosis risk factors and cardiovascular events.
  • To emphasize the need for prospective studies on uric acid reduction and CVD prevention.

Main Methods:

  • Literature review of historical and contemporary studies on uric acid and cardiovascular health.
  • Analysis of associations between uric acid levels and established risk factors for atherosclerosis.
  • Examination of evidence linking uric acid to oxidative stress, endothelial dysfunction, and inflammation.

Main Results:

  • Increased uric acid concentrations are clearly associated with oxidative stress, endothelial dysfunction, inflammation, and subclinical atherosclerosis.
  • Hyperuricemia is an independent marker for cardiovascular disease risk.
  • A strong association exists between elevated uric acid and key risk factors for atherosclerosis.

Conclusions:

  • Elevated uric acid levels are independently associated with increased cardiovascular disease risk.
  • Further prospective studies are required to determine if reducing uric acid levels can prevent cardiovascular events.
  • Hyperuricemia is a significant factor in the complex pathophysiology of cardiovascular disease.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...